Integra LifeSciences Holdings Corporation (IART)
NASDAQ: IART · Real-Time Price · USD
8.94
+0.04 (0.45%)
Mar 20, 2026, 4:00 PM EDT - Market closed

IART Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
6979671,7503,4044,6905,678
Market Cap Growth
-59.04%-44.73%-48.59%-27.42%-17.39%3.71%
Enterprise Value
2,4682,5963,4134,7475,7966,756
Last Close Price
8.9412.4222.6843.5556.0766.99
PE Ratio
--1.84-252.0051.8525.9633.83
Forward PE
3.825.218.8312.9416.1620.19
PEG Ratio
--6.171.541.681.36
PS Ratio
0.430.591.092.213.013.68
PB Ratio
0.670.931.132.142.603.37
P/TBV Ratio
0.660.911.132.202.603.40
P/FCF Ratio
--31.1570.1146.5821.1221.48
P/OCF Ratio
13.8319.2013.5324.3217.7418.17
EV/Sales Ratio
1.511.592.123.083.724.38
EV/EBITDA Ratio
8.29-7.6020.1620.2016.2321.31
EV/EBIT Ratio
16.91-5.26120.1242.5624.2634.26
EV/FCF Ratio
--83.61136.7064.9526.1025.55
Debt / Equity Ratio
1.811.811.251.040.870.94
Debt / EBITDA Ratio
-5.95-5.9511.727.164.525.21
Debt / FCF Ratio
-65.48-65.4879.5023.017.276.25
Net Debt / Equity Ratio
1.701.701.110.860.640.68
Net Debt / EBITDA Ratio
-5.18-5.1810.115.843.243.59
Net Debt / FCF Ratio
-56.98-56.9868.5418.785.224.30
Asset Turnover
0.430.430.410.400.410.42
Inventory Turnover
1.741.741.781.841.831.91
Quick Ratio
1.191.190.591.852.242.19
Current Ratio
2.542.541.173.453.623.39
Return on Equity (ROE)
-39.90%-39.90%-0.44%3.99%10.35%10.57%
Return on Assets (ROA)
-11.84%-11.84%0.28%2.43%5.26%4.20%
Return on Invested Capital (ROIC)
-13.89%-13.89%0.32%2.92%6.54%5.25%
Return on Capital Employed (ROCE)
-15.76%-15.76%0.86%3.17%6.82%5.93%
Earnings Yield
-74.13%-54.27%-0.40%1.93%3.85%2.96%
FCF Yield
-4.46%-3.21%1.43%2.15%4.74%4.66%
Buyback Yield / Dilution
-0.08%-0.08%2.63%7.95%2.55%-0.12%
Total Shareholder Return
--0.08%2.63%7.95%2.55%-0.12%
Updated Feb 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q